---
title: "ROCK: Q2 2026 sales jumped 64.6% on acquisitions, but net income fell due to discontinued operations"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294970308.md"
description: "Net sales surged 64.6% year-over-year in Q2 2026, driven by the OmniMax acquisition, but net income declined due to losses from discontinued operations and higher interest expense. The company completed the divestiture of its Renewables business and increased leverage to fund growth.Original document: Gibraltar Industries, Inc. [ROCK] SEC 10-Q Quarterly Report — Aug. 5 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-05T12:47:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294970308.md)
  - [en](https://longbridge.com/en/news/294970308.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294970308.md)
generator: "portal-rs"
---

# ROCK: Q2 2026 sales jumped 64.6% on acquisitions, but net income fell due to discontinued operations

Net sales surged 64.6% year-over-year in Q2 2026, driven by the OmniMax acquisition, but net income declined due to losses from discontinued operations and higher interest expense. The company completed the divestiture of its Renewables business and increased leverage to fund growth.

Original document: Gibraltar Industries, Inc. \[ROCK\] SEC 10-Q Quarterly Report — Aug. 5 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ROCK.US](https://longbridge.com/en/quote/ROCK.US.md)

## Related News & Research

- [Gibraltar Q2 net sales jump on OmniMax acquisition](https://longbridge.com/en/news/294960201.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [TrueBlue PeopleScout report shows 52% of job seekers use AI in job search, communication gaps persist](https://longbridge.com/en/news/296352258.md)
- [DE: 3Q 2026 saw sales and profit growth, but FY 2026 guidance signals industry headwinds](https://longbridge.com/en/news/296475895.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**